Enveric Biosciences, Inc.
Pharmaceutical ManufacturingMassachusetts, United States11-50 Employees
Enveric Biosciences, Inc. is a Cambridge, Massachusetts-based biotechnology company focused on developing small-molecule therapies that promote neuroplasticity to address depression, anxiety, addiction, and related neuropsychiatric conditions. It operates around a discovery framework called Psybrary, which underpins a pipeline of novel chemical entities for mental health indications. The lead candidate, EB-003, is described as a potential first-in-class neuroplastogen intended to enhance neural plasticity without inducing hallucinatory effects, with clinical development as its near-term objective. Beyond EB-003, the company pursues out-licensing of other patented Psybrary compounds to third-party licensees to enable varied approaches to patient care. Enveric sits in the pharmaceutical manufacturing sector as a smaller biotech company emphasizing external collaboration to advance its portfolio. A recent development includes a January 2026 partnership with Totec Pharma to extend licensing arrangements, illustrating its strategy of leveraging collaborations to extend its pipeline.
1-888-653-2347 
support@leadiq.com 
